Female genital schistosomiasis is a common complication, occurring in approximately 40 million girls and women, making it one of the most common gynecologic conditions in Africa, and schistosome infections have been implicated as cofactors in the acquisition and transmission of HIV and are a WHO-recognized risk factor for HIV infection 4,5
One of the most significant dangers is a lack of sterility
Though coverage for Wegovy (semaglutide) is generally better than for Zepbound this year, 88% of people getting Wegovy through their insurer still face hurdles, including prior authorization and required protocols in which cheaper treatments must be tried first prior to gaining access
F.LipanO.LeykinI.ViswanathanN.DavisF
The first and rate-limiting step is the synthesis of a dipeptide, catalyzed by -glutamylcysteine synthase
The consensus among providers is to wait unless more safety data becomes available